Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for May 28th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 28th:

Westlake Chemical Partners LP (WLKP - Free Report) : This operator of ethylene production facilities and related assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 8%, compared with the industry average of 0.5%. Its five-year average dividend yield is 5.5%.

Southern Copper Corporation (SCCO - Free Report) : This miner and refiner of copper and other minerals has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 4.8%, compared with the industry average of 0%. Its five-year average dividend yield is 1.7%.

HP Inc. (HPQ - Free Report) : This provider of personal computing and related technologies, products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.

HP Inc. Price and Consensus

HP Inc. Price and Consensus

HP Inc. price-consensus-chart | HP Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 3.2%, compared with the industry average of 1.8%. Its five-year average dividend yield is 2.5%.

HP Inc. Dividend Yield (TTM)

HP Inc. Dividend Yield (TTM)

HP Inc. dividend-yield-ttm | HP Inc. Quote

Hewlett Packard Enterprise Company (HPE - Free Report) : This technology company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.

This Zacks Rank #2 company has a dividend yield of 3.1%, compared with the industry average of 0%. Its five-year average dividend yield is 1.7%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>